Neuren Pharmaceuticals LimitedASX: NEU

Positive topline results from Phase 3 trial in Rett syndrome

Dec 7, 2021 at 4:09 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment